In the present study, we show that Rex-1 mRNA and protein are found at high levels in both 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-resistant glioma cell subpopulations and malignant glioblastoma multiforme (GBM) tissue. We used a combination therapy of small interfering RNA (siRNA) against Rex-1 (siRex-1) and BCNU to target GBM cells. Rex-1 siRNA/BCNU treatment resulted in growth inhibition and a diminished S phase. The treatment efficiently induced P38/JNK and Akt/PI3K/GSK3β signaling and led to apoptosis both in vitro and in vivo. We also show that Rex-1/ABCG2 (ATP binding cassette transporter G2)-coexpressing subpopulations were chemoresistant; however, BCNU was not a substrate for ABCG2. siRex-1 treatment led to cell death in GBM subpopulations by promoting apoptosis. Moreover, siRex-1/BCNU combination therapy targeted both the major population and cancer stem cell-like subpopulations. Our findings are important for the development of clinical applications to treat GBM.
Get full access to this article
View all access options for this article.
References
1.
Ali-OsmanF., SteinD.E., RenwickA.1990. Glutathione content and glutathione-S-transferase expression in 1,\3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Cancer Res., 50:6976–6980.
2.
BleauA.M., HambardzumyanD., OzawaT.et al.2009. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell, 4:226–235.
3.
BourguignonL.Y., PeyrollierK., XiaW., GiladE.2008. Hyaluronan–CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J. Biol. Chem., 283:17635–17651.
4.
BrivanlouA.H., GageF.H., JaenischR.et al.2003. Setting standards for human embryonic stem cells. Science, 300:913–916.
5.
D'IppolitoG., DiabiraS., HowardG.A.et al.2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell. Sci., 117:2971–2981.
6.
GhodsA.J., IrvinD., LiuG.et al.2007. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells, 25:1645–1653.
7.
HegiM.E., DiserensA.C., GorliaT.et al.2005. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med., 352:997–1003.
8.
HendersonJ.K., DraperJ.S., BaillieH.S.et al.2002. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells, 20:329–337.
9.
Hirschmann-JaxC., FosterA.E., WulfG.G.et al.2004. A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U.S.A., 101:14228–14233.
10.
HoslerB.A., LaRosaG.J., GrippoJ.F., GudasL.J.1989. Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol. Cell. Biol., 9:5623–5629.
11.
HuT., LiuS., BreiterD.R., WangF.et al.2008. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res., 68:6533–6540.
12.
JiangY., JahagirdarB.N., ReinhardtR.L.et al.2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418:41–49.
13.
KangM.K., KangS.K.2007. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev., 16:837–847.
14.
KangM.K., KangS.K.2008. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells. Biochem. Biophys. Res. Commun., 373:539–544.
15.
KangM.K., HurB.I., KoM.H.et al.2008. Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci., 9:15.
16.
KarlmarkK.R., FreilingerA., MartonE.et al.2005. Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int. J. Mol. Med., 16:987–992.
17.
KondoT., SetoguchiT., TagaT.2004. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. U.S.A., 101:781–786.
18.
LeeJ.W., KotliarovaS., KotliarovY.et al.2006. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9:391–403.
19.
LiL.C., DahiyaR.2002. MethPrimer: Designing primers for methylation PCRs. Bioinformatics, 18:1427–1431.
20.
MarxJ.2003. Mutant stem cells may seed cancer. Science, 301:1308–1310.
21.
MinnitiG., De SanctisV., MuniR.et al.2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 352:987–996.
22.
MonganN.P., MartinK.M., GudasL.J.2006. The putative human stem cell marker, Rex-1 (Zfp42): Structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol. Carcinog., 45:887–900.
23.
NuttC.L., NobleM., ChambersA.F., CairncrossJ.G.2000. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res., 60:4812–4818.
24.
PatchellR.A.1992. Chemotherapy of primary brain tumors. The Chemotherapy Source Book. PerryM.C.Williams & Wilkins: Baltimore, MD, 908–917.
25.
PatrawalaL., CalhounT., Schneider-BroussardR.et al.2005. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2− cancer cells are similarly tumroigenic. Cancer Res., 65:6207–6219.
26.
Ramalho-SantosM., YoonS., MatsuzakiY.et al.2002. ‘‘Stemness'’: Transcriptional profiling of embryonic and adult stem cells. Science, 298:597–600.
27.
RamanJ.D., MonganN.P., LiuL.et al.2006. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Carcinogenesis, 27:499–507.
28.
ReyaT., MorrisonS.J., ClarkeM.F., WeissmanI.L.2001. Stem cells, cancer, and cancer stem cells. Nature, 414:105–111.
29.
RolhionC., Penault-LlorcaF., KemenyJ.L.et al.1999. O6-methylguanine–DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int. J. Cancer, 84:416–420.
30.
ShapiroJ.R., ShapiroW.R.1985. The subpopulations and isolated cell types of freshly resected high grade human gliomas: Their influence on the tumor's evolution in vivo and behavior and therapy in vitro. Cancer Metastasis Rev., 4:107–124.
31.
ShiW., WangH., PanG.et al.2006. Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J. Biol. Chem., 281:23319–23325.
32.
SinghS.K., HawkinsC., ClarkeI.D.et al.2004. Identification of human brain tumor initiating cells. Nature, 432:396–401.
33.
ThompsonJ.R., GudasL.J.2002. Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene. Mol. Cell. Endocrinol., 195:119–133.
34.
WalkerM.D., GreenB., ByarD.P.et al.1980. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med., 303:1323–1329.
35.
Wechsler-ReyaR.J., ScottM.P.2001. The developmental biology of brain tumors. Annu. Rev. Neurosci., 24:385–428.
36.
WheelerG.P., BowdonB.J., GrimsleyJ.A., LloydH.H.1993. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Cancer Res., 34:194–200.
37.
XiaZ., DickensM., RaingeaudJ.et al.1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270:1326–1331.
38.
ZhangJ.Z., GaoW., YangH.B.et al.2006. Screening for genes essential for mouse embryonic stem cell self-renewal using a subtractive RNA interference library. Stem Cells, 24:2661–2668.
39.
ZhouS., SchuetzJ.D., BuntingK.D.et al.2001. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med., 7:1028–1034.
40.
ZhouS., MorrisJ.J., BarnesY.et al.2002. Bcrp1 gene expression is required for normal numbers of side-population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vitro. Proc. Natl. Acad. Sci. U.S.A., 99:12339–12344.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
